Description: Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company's purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways. The Company is engaged in data sharing and ecommerce in the life sciences. The Company focuses on helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use its affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences. It has approximately 10 locations located in the world, through life science research hubs, enabling local services and multi-language support.
Home Page: www.abcellera.com
ABC Technical Analysis
2215 Yukon Street
Vancouver,
BC
V5Y 0A1
Canada
Phone:
44 12 2369 6000
Officers
| Name | Title |
|---|---|
| Dr. Carl L.G. Hansen Ph.D. | CEO, Pres & Chairperson |
| Mr. Andrew Booth M.B.A. | Chief Financial Officer |
| Dr. Veronique Lecault Ph.D. | COO & Director |
| Mr. Tryn T. Stimart Esq., J.D. | Chief Legal Officer, Chief Compliance Officer & Corp. Sec. |
| Dr. Ester Falconer Ph.D. | Chief Technology Officer |
| Mr. Bo Barnhart Ph.D. | Scientific Director |
| Ms. Tiffany Chiu B.Sc., Ph.D. | VP of Communications |
| Mr. Murray McCutcheon Ph.D. | VP of Corp. Devel. |
| Alexandra Weirich M.Sc. | Mang. of Marketing & Communications |
| Caitlin Webster CIPD, M.Sc. | Sr. Mang. of People & Culture |
Exchange: LSE
Country: UK : United Kingdom
Currency: Pence sterling (p)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 31.4465 |
|---|---|
| Trailing PE: | 204.3333 |
| Price-to-Book MRQ: | 3.9861 |
| Price-to-Sales TTM: | 8.3042 |
| IPO Date: | 2005-11-03 |
| Fiscal Year End: | June |
| Full Time Employees: | 1682 |